Targeted molecular therapy for renal cell carcinoma.
Lane
Brian R
BR
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Rini
Brian I
BI
Novick
Andrew C
AC
Campbell
Steven C
SC
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008967:Molecular Biology; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D042442:Vascular Endothelial Growth Factors